Federal Register Notice: FDA is making available a draft document, Guidance for Industry: Early Clinical Trials with Live Biotherapeutic Products: Chemistry, Manufacturing, and Control Information. It provides IND sponsors with recommendations on submitting INDs for early clinical trials with live biotherapeutic products. To download this draft guidance, click here. To view this notice, click here.
